Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationManesh R. Patel, Robert M. Califf, Graeme J. Hankey et al.|New England Journal of Medicine|2011Cited by 9.4k
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentKeith A.A. Fox, Robert M. Califf, Jonathan P. Piccini et al.|European Heart Journal|2011Cited by 614
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial FibrillationJonathan P. Piccini, Robert M. Califf, Susanna R. Stevens et al.|Circulation|2012Cited by 499
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AFSean D. Pokorney, G. Larsen Kneller, Jonathan P. Piccini et al.|Journal of the American Heart Association|2016Cited by 199